Post Acute Sequelae Covid-19 Hyposmia
1 clinical trials · Condition
◉ Watch Post Acute Sequelae Covid-19 Hyposmia
| Record | Firm | Date |
|---|---|---|
| Directed Topical Drug Delivery for Treatment for PASC Hyposmia (NCT05970731) | Duke University | 2023-09-05 |
Track Post Acute Sequelae Covid-19 Hyposmia automatically
Every clearance here is in the API, with alerts when new ones post.